The emerging tech town of St. Louis has also become fertile ground for a community of life sciences companies that are ready to bloom — if they can find early stage funding.
“We’ve got a lot of engineers here who have been working for companies like Sigma-Aldrich and Monsanto that have decided to spin off, so we have some great entrepreneurial ventures in the life sciences,” said Kasey Joyce, the director of investor relations for Cultivation Capital.
To read the original article: Young VC firm Cultivation Capital jumps right into early stage life sciences funding with $30M | MedCity News
